Work

ALK FISH positivity and crizotinib efficacy in patients (pts) with non-small cell lung cancer (NSCLC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9062

Authors: Jean-Charles Soria, Steffan N. Ho, Marileila Varella-Garcia, A. John Iafrate, Benjamin J. Solomon, Alice T. Shaw, Fiona Helen Blackhall, Tony Mok, Yi-Long Wu, Ekaterina Pestova, Fred W. Siebert, Keith D. Wilner, Anna Polli, Jolanda Paolini, Silvana Lanzalone, Stephanie J. Green, D. Ross Camidge

Institutions: Institut Gustave Roussy, Pfizer (United States), University of Colorado Cancer Center, Massachusetts General Hospital, Peter MacCallum Cancer Centre, University of Manchester, The Christie Hospital, Chinese University of Hong Kong, Guangdong General Hospital, Abbott (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890747788

Cites:

Cited by:

Related to: 10